Minnesota has a thriving research community, new buildings, high funding levels and is currently attracting top life science research professionals from around the world.
Laboratory supply companies with new or improved products can meet with researchers at some of the top Minnesota research institutes this July at the largest research product vendor events on produced on these campuses. Your participation brings these top scientists the most advanced tools and techniques in industry and helps push back the frontiers of science nationwide.
Mayo Clinic is leading research supported by a $48 million grant from the National Institutes of Health and industry to research treatment of atrial fibrillation in 3,000 patients in 140 centers around the world. Mayo Clinic was awarded $11.2 million to continue research in Pharmacogenomics. Mayo Clinic receives $369 million in government, foundation and industry funding. Mayo Clinic funds and benefactor gifts are $400 million.
For more research funding and building stats click button below:
Twin Cities BioResearch Product Faire™ Event at University of Minnesota, Twin Cities Thursday, July 26, 2012
The University of Minnesota's Academic Health Center is a $1.2 billion organization, receiving in excess of $395 million in sponsored research.
Since 2004, the University of Minnesota research portfolio has grown by 41% – the second-highest growth rate among U.S. public research universities. Now ranked 9th among the nation’s top research universities, in 2010 the the University of Minnesota garnered a record $823M in outside research funding. In addition, University-based technologies figured prominently in the launch of 14 new companies in the past 18 months. And gross annual revenues from patent and licensing activity were nearly $84M in 2010.
The University of Minnesota has received a $51 million, five-year Clinical and Translational Science Award from the National Institutes of Health. The money will be devoted to researching five broad disease categories: diabetes, cancer, cardiology, neurological disorders and infectious diseases.
For more research funding and building stats click button below:
BioResearch Product Faire™ Frontline Event at University of Minnesota, St. Paul Friday, July 27, 2012
The University of Minnesota College of Veterinary Medicine is one of the nation’s premier centers for the study of animal and human health and the education of veterinarians and biomedical scientists.Both Minneapolis Twin Cities and St. Paul campuses together have a very active research community withtop funded programs:
- NSF 2009 Ranking: 10th (total R&D expenditures in life sciences for both campuses) = $529,128,000
- NIH 2011 Ranking: 19th (Direct plus indirect costs but excluding R & D contracts and ARRA awards) = $248,701,501
- The University of Minnesota's Academic Health Center is a $1.2 billion organization, receiving in excess of $395 million in sponsored research.
Since 2004, the University of Minnesota research portfolio has grown by 41% – the second-highest growth rate among U.S. public research universities. Now ranked 9th among the nation’s top research universities, in 2010 the the University of Minnesota garnered a record $823M in outside research funding. In addition, University-based technologies figured prominently in the launch of 14 new companies in the past 18 months. And gross annual revenues from patent and licensing activity were nearly $84M in 2010.
The University of Minnesota has received a $51 million, five-year Clinical and Translational Science Award from the National Institutes of Health. The money will be devoted to researching five broad disease categories: diabetes, cancer, cardiology, neurological disorders and infectious diseases.
For more research funding and new development information click below:
Lastly the Minnesota Partnership for Biotechnology and Medical Genomics announced six new projects in 2010. The Partnership rewarded $5 million in state funded research support to six new investigative teams in 2010 to provide the initial support for research on cancer, neurological conditions and autoimmune diseases. The Partnership is a collaboration of the State of Minnesota, the University of Minnesota, and Mayo Clinic.
